Maryland Drug Testing Laws for Employers

A Statute About the Aftermath

Md. Code, Health-General 17-214 is unusual in what it covers. It regulates laboratory permits and accreditation, instant screening devices, hair specimens, post-positive notice, the right to independent verification testing, confidentiality of prescription information, medical review officer review and collector training. It supplies no grounds for testing, requires no reasonable suspicion, and offers no voluntary program with incentives.

Its reach is broad. Subsection (h) states the section applies to job-related testing of any person, including preemployment applicants, employees and contractors, and subsection (a)(6) defines job-related as any testing used by an employer for a legitimate business purpose. Contractors are inside the statute, which multi-state employers with contingent workforces regularly miss.

The 30-Day Package

This is the center of Maryland compliance. After a confirmed positive, the employer must provide four things:

1. A copy of the test result.
2. A copy of the employer's written policy on the use or abuse of controlled dangerous substances or alcohol by employees, contractors or other persons.
3. Written notice of any intended disciplinary action.
4. A statement of the right to independent verification testing of the same specimen, at a permitted or approved laboratory, at the person's own cost.

Delivery must be in person or by certified mail, within 30 days from the date the test was performed. Note the clock starts at the test date, not at the date you received the result — so laboratory turnaround and internal review both eat into the window.

Item two is where employers get caught. Maryland never separately tells you to adopt a written policy, so an employer can run a program for years without one and only discover the gap at the moment it wants to act on a positive. At that point the requirement is not satisfiable retrospectively.

Method Limits That Shape the Program

Maryland does not restrict when you test, so the constraints land on how:

• Permitted laboratories. Any job-related specimen must be tested by a laboratory holding a Maryland permit, or an out-of-state laboratory certified or approved under 17-214(f). Confirmation laboratories must be inspected and accredited in forensic drug analysis, with cutoff levels following HHS or Secretary-established workplace guidelines.
• Instant devices, applicants only. Preliminary screening procedures may be used on job applicants, and not on anyone who is not applying for a job with that employer. Any positive goes to a permitted or approved laboratory.
• Hair, pre-employment only, inch and a half. The specimen may not exceed one and one-half inches measured from the body, and may not be used for any purpose beyond controlled dangerous substance testing.
• Laboratory disclosure on request. At the time of testing, on the person's request, the employer must give the name and address of the laboratory that will test the specimen.
• Chain of custody for single-use devices, with specimen identity, confidentiality and integrity protected and a written record maintained.

So a random or reasonable-suspicion program in Maryland runs through a permitted laboratory on blood, urine or saliva, and every confirmed positive triggers the 30-day package and the independent verification right.

Two Requirements Employers Forget They Own

Where an employer uses preliminary screening procedures, 17-214(j) requires a medical review officer to review a positive result after laboratory confirmation, with outside contracting permitted. And 17-214(k) requires the employer to establish a training program for the individuals who collect specimens and perform the tests, with specified instruction, competency demonstration and recordkeeping. That second obligation sits with the employer, not the vendor, and is rarely documented until someone asks for it.

Prescription Confidentiality

17-214(i)(1) bars a laboratory, physician or other person from revealing to the employer the use of a lawful nonprescription drug, or of a medically prescribed drug unless the person cannot establish the prescription. That bar yields to the federal Commercial Motor Vehicle Safety Act of 1986 and the Federal Motor Carrier Safety Regulations.

There is also a narrow pre-test notification that unlocks disclosure: under 17-214(i)(3), the confidentiality bar does not apply if, before a preliminary screening, the test operator notifies the applicant that a positive preliminary result may be voluntarily explained with documentation of a legally prescribed medication. Where that disclosure happens, 17-214(b)(2)(iii) lets the employer hire the applicant pending laboratory confirmation and MRO review.

Union Agreements Override Applicant Screening

One provision is easy to overlook in a unionized workforce. Md. Code, Health-General 17-214(l) provides that collective bargaining provisions concerning drug testing override and preempt the section's authorization for an employer to use a preliminary screening procedure on a job applicant. If your agreement addresses testing, check it before assuming the instant-cup allowance is available to you.

Where This Lands

Maryland's employment base is heavy on federal government, defense and government contracting, healthcare and biosciences, professional and technical services including cybersecurity, education and research, port operations and logistics, construction, and finance. A large share of those employers already run federally driven testing, which has its own rules. For everyone else the two practical jobs are simple to state: have a written policy on file, and build a process that can deliver the package inside 30 days of the test date.